Kapil Dhingra - Apr 1, 2023 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Director
Signature
/s/ Jean Franchi, attorney-in-fact
Stock symbol
REPL
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 08:03 PM
Previous filing
Jun 13, 2022
Next filing
May 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Stock Option (right to buy) Award $0 +25.2K $0.00 25.2K Apr 1, 2023 Common Stock 25.2K $17.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest entirely on April 1, 2024.